Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $104.45 USD
Change Today +0.24 / 0.23%
Volume 849.4K
INCY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - INCYTE CORP (INCY)

Incyte Corporation to Report Q1, 2015 on Apr 30, 2015
CapIQ 04/30/2015 12:00 PM ET
Incyte Corporation to Report Q4, 2014 on Feb 12, 2015
CapIQ 04/30/2015 12:00 PM ET
Incyte Corporation to Report Q3, 2014 on Oct 30, 2014
CapIQ 04/30/2015 12:00 PM ET

2013 revenues at Incyte Corporation totaled $354.9M USD, while annual losses equaled $0.44 per share.

Quarterly Earnings & Estimates - INCYTE CORP (INCY)

Actuals vs. Estimates for INCYTE CORP INCY

Incyte Corporation's Quarterly Earnings

Incyte Corporation reported 2nd quarter 2014 losses of $0.22 per share on 08/2/2014.

Annual Earnings & Estimates - INCYTE CORP (INCY)

Actuals vs. Estimates for INCYTE CORP INCY

Incyte Corporation's Annual Earnings

Incyte Corporation reported annual 2013 losses of $0.44 per share on 02/14/2014.

Quarterly Revenues - INCYTE CORP (INCY)

Actuals vs. Estimates for INCYTE CORP INCY

Incyte Corporation's Quarterly Revenues

Incyte Corporation had 2nd quarter 2014 revenues of $99.6M USD. This missed the $128.9M USD consensus estimate of the 14 analysts following the company. This was -2.1% below the prior year's 2nd quarter results.

Annual Revenues - INCYTE CORP (INCY)

Actuals vs. Estimates for INCYTE CORP INCY

Incyte Corporation's Annual Revenues

Incyte Corporation had revenues for the full year 2013 of $354.9M USD. This was 19.5% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INCY:US $104.45 USD +0.24

INCY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alkermes PLC $64.77 USD +0.43
ARIAD Pharmaceuticals Inc $8.09 USD -0.18
BioMarin Pharmaceutical Inc $136.73 USD -0.05
Jazz Pharmaceuticals PLC $177.13 USD +1.06
Vertex Pharmaceuticals Inc $126.19 USD +2.71
View Industry Companies
 

Industry Analysis

INCY

Industry Average

Valuation INCY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 30.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 29.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INCYTE CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.